Literature DB >> 12132085

Flexor tendon healing in vitro: effects of TGF-beta on tendon cell collagen production.

Matthew B Klein1, Naveen Yalamanchi, Hung Pham, Michael T Longaker, James Chang.   

Abstract

Flexor tendon healing is complicated by adhesions to the surrounding sheath. Transforming growth factor beta (TGF-beta) is a cytokine with numerous activities related to wound healing. We examined the effects of TGF-beta-1, -2 and -3 on tendon cell proliferation and collagen production. Three separate cell lines--sheath fibroblasts, epitenon and endotenon tenocytes--were isolated from rabbit flexor tendons and cultured separately. Cell culture media was supplemented with 1 or 5 ng/mL of TGF-beta-1, -2, or -3. Cell number and collagen I and III production were measured and compared with unsupplemented control cultures. The addition of TGF-beta to cell culture media resulted in a decrease in cell number in all 3 lines that did not reach statistical significance. There was a significant increase (p <.05) in collagen I and III production with the addition of all 3 TGF-beta isoforms. Modulation of TGF-beta production may provide a mechanism to modulate adhesion formation clinically.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132085     DOI: 10.1053/jhsu.2002.34004

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  56 in total

1.  Recent Scientific Advances Towards the Development of Tendon Healing Strategies.

Authors:  Eli T Sayegh; John D Sandy; Mandeep S Virk; Anthony A Romeo; Robert W Wysocki; Jorge O Galante; Katie J Trella; Anna Plaas; Vincent M Wang
Journal:  Curr Tissue Eng       Date:  2015

2.  Does single intramuscular application of autologous conditioned plasma influence systemic circulating growth factors?

Authors:  Gert Schippinger; Florian Fankhauser; Karl Oettl; Stefan Spirk; Peter Hofmann
Journal:  J Sports Sci Med       Date:  2012-09-01       Impact factor: 2.988

3.  Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.

Authors:  Chiara Gomiero; Giulia Bertolutti; Tiziana Martinello; Nathalie Van Bruaene; Sarah Y Broeckx; Marco Patruno; Jan H Spaas
Journal:  Vet Res Commun       Date:  2016-01-13       Impact factor: 2.459

Review 4.  Considerations for the use of platelet-rich plasma in orthopedics.

Authors:  Taralyn M McCarrel; Nathan A Mall; Andrew S Lee; Brian J Cole; Davietta C Butty; Lisa A Fortier
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

5.  Expression of cytoskeletal, linkage and extracellular proteins in failing dog myocardium.

Authors:  Victor G Sharov; Sawa Kostin; Anastassia Todor; Jutta Schaper; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

Review 6.  Tendon stem progenitor cells: Understanding the biology to inform therapeutic strategies for tendon repair.

Authors:  Bhavita Walia; Alice H Huang
Journal:  J Orthop Res       Date:  2018-10-18       Impact factor: 3.494

7.  HGF suppresses the production of collagen type III and alpha-SMA induced by TGF-beta1 in healing fibroblasts.

Authors:  Dapeng Jiang; Zhitao Jiang; Fuyou Han; Yubo Zhang; Zhaozhu Li
Journal:  Eur J Appl Physiol       Date:  2008-04-02       Impact factor: 3.078

8.  Controlled-release kinetics and biologic activity of platelet-derived growth factor-BB for use in flexor tendon repair.

Authors:  Shelly E Sakiyama-Elbert; Rosalina Das; Richard H Gelberman; Fredrick Harwood; David Amiel; Stavros Thomopoulos
Journal:  J Hand Surg Am       Date:  2008-11       Impact factor: 2.230

9.  Outcome of early active mobilization after flexor tendons repair in zones II-V in hand.

Authors:  Narender Saini; Vishal Kundnani; Purnima Patni; Sp Gupta
Journal:  Indian J Orthop       Date:  2010-07       Impact factor: 1.251

10.  bFGF and PDGF-BB for tendon repair: controlled release and biologic activity by tendon fibroblasts in vitro.

Authors:  Stavros Thomopoulos; Rosalina Das; Shelly Sakiyama-Elbert; Matthew J Silva; Nichole Charlton; Richard H Gelberman
Journal:  Ann Biomed Eng       Date:  2010-02       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.